Olaf Heidenreich
- Hematology top 1%
- Acute Myeloid Leukemia Research 53
- Molecular Biology top 2%
- RNA Interference and Gene Delivery 31
- Protein Degradation and Inhibitors 27
- Advanced biosensing and bioanalysis techniques 20
- Histone Deacetylase Inhibitors Research 11
- RNA and protein synthesis mechanisms 10
- Cancer Research top 5%
- Immunology top 5%
- Oncology top 5%
- CAR-T cell therapy research 11
-
- Acute Lymphoblastic Leukemia research 22
- Co-authors
- F. EcksteinMichael NerenbergJosef VormoorAlfred NordheimArnold GanserSimon BomkenShin Hyeok KangXin Xu
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
Olaf Heidenreich
129 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 123
- Hematology 1.1k
- Molecular Biology 3.0k
- Cancer Research 491
- Immunology 609
- Oncology 613
Countries citing papers authored by Olaf Heidenreich
This map shows the geographic impact of Olaf Heidenreich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Heidenreich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Heidenreich more than expected).
Fields of papers citing papers by Olaf Heidenreich
This network shows the impact of papers produced by Olaf Heidenreich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Heidenreich. The network helps show where Olaf Heidenreich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olaf Heidenreich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 17 | |
| 12 | 2023 | 16 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 14 | |
| 15 | 2021 | 6 | |
| 16 | 2020 | 2 | |
| 17 | 2019 | 3 | |
| 18 | 2010 | 11 | |
| 19 | 2002 | 3 | |
| 20 | Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. | 1996 | 78 |
About Olaf Heidenreich
Olaf Heidenreich is a scholar working on Hematology, Molecular Biology and Immunology, having authored 136 papers that have together received 4.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (53 papers), RNA Interference and Gene Delivery (31 papers), Protein Degradation and Inhibitors (27 papers), Acute Lymphoblastic Leukemia research (22 papers), Advanced biosensing and bioanalysis techniques (20 papers), Histone Deacetylase Inhibitors Research (11 papers), CAR-T cell therapy research (11 papers) and RNA and protein synthesis mechanisms (10 papers). The work is most often cited by research in Hematology (1.1k citations), Molecular Biology (3.0k citations) and Cancer Research (491 citations). Olaf Heidenreich has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include F. Eckstein, Michael Nerenberg, Josef Vormoor, Alfred Nordheim, Arnold Ganser, Simon Bomken, Shin Hyeok Kang, Xin Xu, Gerhard Schratt and Karel Fišer. Their work appears in journals such as Leukemia, Blood, Cell Reports, Journal of Biological Chemistry and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.